Evoke Pharma, Inc. (EVOK) is a publicly traded Healthcare sector company. As of September 29, 2026, EVOK trades at $11.00 with a market cap of $18.95M and a P/E ratio of -7.97. EVOK moved +0.18% today. Year to date, EVOK is +291.46%; over the trailing twelve months it is flat. Its 52-week range spans $1.94 to $11.00. Analyst consensus is buy with an average price target of $18.00. Rallies surfaces EVOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for EVOK, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $11.00 |
| Market Cap | $18.95M |
| P/E Ratio | -7.97 |
| EPS | $-1.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.00 |
| 52-Week Low | $1.94 |
| Volume | 47.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.42M |
| Net Income | $-5.23M |
| Gross Margin | 0.00% |
12 analysts cover EVOK: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $18.00.